Weight Loss Medications – Ozempic and Mounjaro

In 2024, weight-loss medications gained significant popularity, but will this trend continue into 2025?

GLP-1 medications, such as Ozempic and Mounjaro, have emerged as increasingly favored options for weight loss treatment. At Bionix, clients typically lose about 5 kg per month, with some achieving up to 20 kg within three months. Research indicates that Mounjaro resulted in at least a 5% weight loss in 81.8% of adults within a year, compared to 66.5% of those using Ozempic.

If your primary goal is weight loss, alternative options also exist, including Wegovy (semaglutide) and Zepbound (tirzepatide), both of which have been approved for long-term weight management. A consultation with a doctor can determine the most suitable brand for your needs. These injectable weight-loss treatments are administered weekly as subcutaneous injections in the abdomen, thigh, or upper arm, and they are available in oral tablet forms as well.

In addition to aiding weight loss, these treatments can help achieve your A1C goals, potentially preventing diabetes-related complications such as heart disease, nerve damage, kidney failure, and vision loss.

For Mounjaro, the suggested starting dose is 2.5 mg subcutaneously weekly, increasing to 5 mg after four weeks.

For Ozempic, the initial dose is 0.25 mg weekly, increasing to 0.5 mg after four weeks, with further increases possible based on glycemic needs. The maximum dosage for Ozempic is 2 mg weekly.

At our clinic, the following services are included in the prices: – Consultation with a doctor and a nurse – RF cavitation to mitigate side effects – Diet plan and ongoing support to minimize common gastrointestinal side effects like nausea, vomiting, and diarrhea, you will begin treatment at lower doses.

Pricing is as follows:

Ozempic:
1499 / month, including radiofrequency and medical check-ups.

Mounjaro:
2799 / month, including radiofrequency and medical check-ups.